Dolly firm faces the chop
The axe looks set to fall on Scottish biotechnology company PPL Therapeutics now that the company put itself up for sale, having failed to convince investors of a rescue plan.
Archives for September 15, 2003
AnaSpec buys fluorescence firm
Peptide and antibody specialist AnaSpec has acquired HiLyte Biosciences, which makes bioanalytical research reagents and kits designed for scientists engaged in life science research and drug discovery.
Mapping pathways in immunology
A team of researchers at Switzerland's Novartis and Rigel Pharmaceuticals in the USA have created a method for discovering molecules that are involved in signalling pathways, according to a report in the Journal of Biology.
BMS has insulin in its sights
Bristol-Myers Squibb has taken another step towards building a franchise in insulin therapy by licensing an inhaled version of the drug from QDose for $30m.
New antibiotic class cleared for market
The first in a new class of antibiotics has been approved in the USA for the treatment of complicated skin and soft structure infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA).
New tools of the trade
New products this week include: a kit for isolating RNA from blood; a DNA microarray for cytogenetics and cancer research; an automated mammalian cell picker; and a reagent dispenser for a microplate reader.